共 328 条
[1]
Buys SS(2011)Effect of screening on ovarian cancer mortality: the prostate, lung, colorectal and ovarian (PLCO) cancer screening randomized controlled trial JAMA 305 2295-2303
[2]
Partridge E(2021)Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial Lancet 397 2182-2193
[3]
Black A(2018)Screening for ovarian cancer: updated evidence report and systematic review for the US preventive services task force JAMA 319 595-606
[4]
Johnson CC(2015)Society of gynecologic oncology recommendations for the prevention of ovarian cancer Cancer 121 2108-2120
[5]
Lamerato L(2021)Time-dependent effects of oral contraceptive use on breast, ovarian, and endometrial cancers Cancer Res 81 1153-1162
[6]
Isaacs C(2013)Oral contraceptive use for the primary prevention of ovarian cancer Evid Rep Technol Assess (Full Rep) 212 1-514
[7]
Menon U(2021)The origin of ovarian cancer species and precancerous landscape Am J Pathol 191 26-39
[8]
Gentry-Maharaj A(2003)BRCA1/2-related ovarian cancers are of tubal origin: a hypothesis Gynecol Oncol 90 491-58
[9]
Burnell M(2013)Fallopian tube precursors of ovarian low- and high-grade serous neoplasms Histopathology 62 44-71
[10]
Singh N(2018)Fallopian tube tumorigenesis and clinical implications for ovarian cancer risk-reduction Cancer Treat Rev 69 66-521